Literature DB >> 18609108

Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa-foeto-protein (AFP), neuron-specific enolase (NSE) and CA19.9 from the NORIP study.

Johan Bjerner1, Anita Høgetveit, Katrine Wold Akselberg, Kirsti Vangsnes, Elisabeth Paus, Trine Bjøro, Ole Petter Børmer, Kjell Nustad.   

Abstract

OBJECTIVE: Adhering to current IFCC recommendations, we calculated upper 97.5 % reference limits for serum tumor markers.
MATERIAL AND METHODS: Serum samples from 498 healthy individuals from the Nordic reference interval project (NORIP) were investigated for carcinoembryonic antigen (CEA), CA125 and MUC1 (episialin, CA15.3) using in-house immunofluorometric assays and, for alpha-foetoprotein (AFP), a PerkinElmer Life Sciences assay, neuron-specific enolase (NSE) using an in-house immunoradiometric assay and CA19.9 using a Beckman Access assay. All assays participate in external quality assessment programs.
RESULTS: CEA concentrations increased with age and smoking. Upper reference limits for non-smokers were 3.59 microg/L at 50 years and 4.12 microg/L at 70 years. CA125 concentrations were age-independent and the upper reference limit was 35.8 kU/L. MUC1 increased with age and body mass index (BMI). Upper reference limits were 31.7 kU/L at 40 years and BMI 24, 37.5 kU/L at 70 years and BMI 24, and 33.7 kU/L at 40 years and BMI 30. AFP increases with age, and the upper reference limits were 3.82 kU/L at 20 years and 8.70 kU/L at 60 years. An upper reference limit for NSE was 8.91 microg/L in non-smokers; smokers exhibited significantly lower levels. The upper reference limit for individuals expressing CA19.9 was 28.3 kU/L.
CONCLUSIONS: For AFP, CA125 and CA19.9, the reference levels obtained were close to previously reported reference ranges. Smoking and age were confirmed as covariates for CEA. The associations between MUC1 with age and BMI and between NSE and smoking have not been reported previously.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18609108     DOI: 10.1080/00365510802126836

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  11 in total

1.  Prognostic value of preoperative D-dimer and carcinoembryonic antigen levels in patients undergoing intended curative resection for colorectal cancer: a prospective cohort study.

Authors:  Ehsan Motavaf; Kåre Gotschalck Sunesen; Mogens Tornby Stender; Ole Thorlacius-Ussing
Journal:  Int J Colorectal Dis       Date:  2014-08-23       Impact factor: 2.571

2.  Reference intervals of carbohydrate antigen 19-9 in the apparently healthy adult population.

Authors:  Gao-Ming Zhang; Shu-Mei Bai; Guo-Ming Zhang; Xiao-Bo Ma
Journal:  J Clin Lab Anal       Date:  2018-01-08       Impact factor: 2.352

3.  Human epididymis protein 4 reference limits and natural variation in a Nordic reference population.

Authors:  Nils Bolstad; Miriam Øijordsbakken; Kjell Nustad; Johan Bjerner
Journal:  Tumour Biol       Date:  2011-11-22

4.  Improved tumour marker sensitivity in detecting colorectal liver metastases by combined type IV collagen and CEA measurement.

Authors:  Hanna Nyström; Björn Tavelin; Moa Björklund; Peter Naredi; Malin Sund
Journal:  Tumour Biol       Date:  2015-07-11

5.  Correlates of circulating ovarian cancer early detection markers and their contribution to discrimination of early detection models: results from the EPIC cohort.

Authors:  Renée T Fortner; Allison F Vitonis; Helena Schock; Anika Hüsing; Theron Johnson; Raina N Fichorova; Titilayo Fashemi; Hidemi S Yamamoto; Anne Tjønneland; Louise Hansen; Kim Overvad; Marie-Christine Boutron-Ruault; Marina Kvaskoff; Gianluca Severi; Heiner Boeing; Antonia Trichopoulou; Vassiliki Benetou; Carlo La Vecchia; Domenico Palli; Sabina Sieri; Rosario Tumino; Giuseppe Matullo; Amalia Mattiello; N Charlotte Onland-Moret; Petra H Peeters; Elisabete Weiderpass; Inger Torhild Gram; Mie Jareid; J Ramón Quirós; Eric J Duell; Maria-Jose Sánchez; María Dolores Chirlaque; Eva Ardanaz; Nerea Larrañaga; Björn Nodin; Jenny Brändstedt; Annika Idahl; Kay-Tee Khaw; Naomi Allen; Marc Gunter; Mattias Johansson; Laure Dossus; Melissa A Merritt; Elio Riboli; Daniel W Cramer; Rudolf Kaaks; Kathryn L Terry
Journal:  J Ovarian Res       Date:  2017-03-20       Impact factor: 4.234

6.  Prognostic role of alpha-fetoprotein response after hepatocellular carcinoma resection.

Authors:  Narongsak Rungsakulkij; Wikran Suragul; Somkit Mingphruedhi; Pongsatorn Tangtawee; Paramin Muangkaew; Suraida Aeesoa
Journal:  World J Clin Cases       Date:  2018-06-16       Impact factor: 1.337

7.  Reference Intervals of Alpha-Fetoprotein and Carcinoembryonic Antigen in the Apparently Healthy Population.

Authors:  Gao-Ming Zhang; Xu-Xiao Guo; Xiao-Bo Ma; Guo-Ming Zhang
Journal:  Med Sci Monit       Date:  2016-12-12

8.  Comparison of Four Automated Carcinoembryonic Antigen Immunoassays: ADVIA Centaur XP, ARCHITECT I2000sr, Elecsys E170, and Unicel Dxi800.

Authors:  Joonhong Park; Seungok Lee; Yeongsic Kim; Aeran Choi; Hyeyoung Lee; Jihyang Lim; Yonggoo Kim; Kyungja Han; Eun Jee Oh
Journal:  Ann Lab Med       Date:  2018-07       Impact factor: 3.464

9.  Reference limits for chromogranin A, CYFRA 21-1, CA 125, CA 19-9 and carcinoembryonic antigen in patients with chronic kidney disease.

Authors:  Gustav Mikkelsen; Arne Åsberg; Maria E Hultström; Knut Aasarød; Gunhild G Hov
Journal:  Int J Biol Markers       Date:  2017-10-31       Impact factor: 2.659

10.  Evaluation of an Element-Tagged Duplex Immunoassay Coupled with Inductively Coupled Plasma Mass Spectrometry Detection: A Further Study for the Application of the New Assay in Clinical Laboratory.

Authors:  Wencan Jiang; Gongwei Sun; Wenbin Cui; Shasha Men; Miao Jing; Danna Pu; Sichun Zhang; Xiaozhou Yuan; Xinrong Zhang; Chengbin Wang
Journal:  Molecules       Date:  2020-11-17       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.